期刊文献+

门脉高压症发病机理的研究近况 被引量:12

RESENT STUDY OF PATHOGENESIS IN PORTAL HYPERTENSION
暂未订购
导出
摘要 目的 了解内毒素、细胞因子、一氧化氮在门脉高压症发生高动力循环综合征中所起的作用。方法 综述了近 10年来国外对门脉高压症发生高动力循环综合征的研究和认识。结果 所有门脉高压动物模型及 30 %~ 5 0 %的肝硬变患者均存在高动力循环综合征。内毒素、细胞因子、一氧化氮在高动力循环综合征形成中所起作用的研究结果还不一致。结论 是高动力循环综合征维持和加剧了门脉高压。内毒素、细胞因子、一氧化氮在高动力循环综合征发生中可能起作用 ,其中一氧化氮较为重要 。 Objective The effects of endotoxin, cytokines, nitric oxide were reviewed in the development of hyperdynamic circulatory syndrome in portal hypertension. Methods Liceratures of overseas main studies in hyperdynamic circulatory syndrome of portal hypertension in recent 10 years were reviewed. Results The hyperdynamic circulatory syndrome was found in 30%-50% of patients with cirrhosis and in all animal models of portal hypertension. The research results of the effects of endotoxin, cytokines, nitric oxide in the development of hyperdynamic circulatory syndrome were different. [WT5”HZ]Conclusion [WT5”BZ]Hyperdynamic circulatory syndrome contribute to the maintenance and aggregation of portal hypertension. Endotoxin, cytokines, nitric oxide may play a role in the development of hyperdynamic circulatory syndrome. Nitric oxide is a more important factor. The effect of other factors is probably mediated by nitric oxide.
出处 《中国普外基础与临床杂志》 CAS 2000年第4期275-276,F003,共3页 Chinese Journal of Bases and Clinics In General Surgery
关键词 内毒素 细胞因子 一氧化氮 门脉高压症 发病机理 Hyperdynamic circulatory syndrome Endotoxin Cytokines Nitric oxide
  • 相关文献

参考文献19

  • 11,Lopez-Talavera JC, Cadelina G, Olchowski J, et al. Thalidomide inhibits tumor necrosis factor, decreases nitric oxide synthesis, and ameliorate the hyperdynamic circulatory syndrome in portal-hypertensive rats [J]. Hepatology, 1996; 23(6)∶1616
  • 22,Stark ME, Szurszewski JH. Role of nitric oxide in gastrointestenal and hepatic function and disease [J]. Gastroenterology, 1992; 103(6)∶1928
  • 33,Colombato LA, Albillos A, Groszmann RJ. Temporal relationship of peripheral vasodilation, plasma volume expansion and the hyperdynamic circulatory state in portal-hypertensive rats [J]. Hepatology, 1992; 15(2)∶323
  • 44,Albillos A, Colombato LA, Groszmann RJ. Vasodilatation and sodium retention in perhepatic protal hypertension [J]. Gastroenterology, 1992; 102(3)∶931
  • 55,Suffredini AF, Fromm RF, Parker MM, et al. The cardivascular response of normal humans to the administration of endotoxin [J]. N Engl J Med, 1989; 321(5)∶280
  • 66,Lumsden AB, Henderson M, Kutner MH. Endtoxin levels measured by a chromogenic assay in portal hepatic and peripheral venous blood in patients with cirrhosis [J]. Hepatology, 1988; 8(2)∶2327Bigatello LM, Broitman SA, Fattori L, et al. Endotoxemia, encephalopathy, and mortality in cirrhotic patients [J].Am J Gastroenterol, 1987; 82(1)∶11
  • 78,Mehta R, Gottstein J, Zeller WP, et al. Endotoxin and hyperdynamic circulation of partal vein-ligated rats [J]. Hepatology, 1990; 12(5)∶1152
  • 89,Nishida T, Huang TP, Seiyama A, et al. Endothelin A-receptor blockade worsens endotoxin-induced hepatic microcirculatory changes and necrosis [J]. Gastroenterology, 1998; 115(2)∶412
  • 910,Deviere J, Content J, Denys C, et al. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis [J]. Hepatology, 1990; 11(4)∶628
  • 1011,Nawroth PP, Bank I, Handley D, et al. Tumor necrosis factor/cachectin interacts with endothelial cell receptor to induce release of interleukin-1 [J]. J Exp Med, 1986; 163(6)∶1363

同被引文献105

引证文献12

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部